Neuromyelitis optica spectrum disorders and pregnancy: relapse-preventive measures and personalized treatment strategies

Tools

Item Type:	Review
Title:	Neuromyelitis optica spectrum disorders and pregnancy: relapse-preventive measures and personalized treatment strategies
Creators Name:	Borisow, N., Hellwig, K. and Paul, F.
Abstract:	Neuromyelitis optica spectrum disorders (NMOSD) are autoimmune inflammatory diseases of the central nervous system that predominately affect women. Some of these patients are of childbearing age at NMOSD onset. This study reviews, on the one hand, the role NMOSD play in fertility, pregnancy complications and pregnancy outcome, and on the other, the effect of pregnancy on NMOSD disease course and treatment options available during pregnancy. Animal studies show lower fertility rates in NMOSD; however, investigations into fertility in NMOSD patients are lacking. Pregnancies in NMOSD patients are associated with increased disease activity and more severe disability postpartum. Some studies found higher risks of pregnancy complications, e.g., miscarriages and preeclampsia. Acute relapses during pregnancy can be treated with methylprednisolone and/or plasma exchange/immunoadsorption. A decision to either stop or continue immunosuppressive therapy with azathioprine or rituximab during pregnancy should be evaluated carefully and factor in the patient's history of disease activity. To this end, involving neuroimmunological specialist centers in the treatment and care of pregnant NMOSD patients is recommended, particularly in specific situations like pregnancy.
Keywords:	Neuromyelitis Optica, Devic's Syndrome, Pregnancy, Relapse Prevention, Personalized Treatment
Source:	EPMA Journal
ISSN:	1878-5085
Publisher:	Springer
Volume:	9
Number:	3
Page Range:	249-256
Date:	September 2018
Official Publication:	https://doi.org/10.1007/s13167-018-0143-9
External Fulltext:	View full text on PubMed Central
PubMed:	View item in PubMed

Repository Staff Only: item control page